Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance [PDF]
, 2012 Trypanosoma brucei rhodesiense (Tbr) and T. b. gambiense (Tbg), causative agents of Human African Trypanosomiasis (sleeping sickness) in Africa, have evolved alternative mechanisms of resisting the activity of trypanosome lytic factors (TLFs), components
A MacLeod +31 more
core +20 more sources
Serum Sickness-Like Reaction Associated with Epstein – Barr Virus: Clinical Case
Вопросы современной педиатрии, 2022 Background. Annular dermatoses are a group of diseases with major clinical manifestation of rashes of relevant form. This manifestation pattern causes difficulties in diagnosis.
Vladislav V. Ivanchikov +3 more
doaj +1 more source
Pathophysiology and clinical manifestations of immune complex vasculitides
Frontiers in Medicine, 2023 Immune complex (IC) vasculitides present inflammations of vessel walls associated with perivascular deposition of immunoglobulins (Igs), mostly ICs. They encompass systemic and skin-limited variants of IgA vasculitis (IgAV), cryoglobulinemic vasculitis ...
Cord Sunderkötter +3 more
doaj +1 more source
Correction: Serum sickness-like reaction to D-Supplement: A Case Report [PDF]
BMC PediatricsEmma R. Plante +3 more
doaj +2 more sources
Serum-Sickness in Rabbits [PDF]
The Journal of Immunology, 1931 Abstract The studies here reported relate primarily to the rôle that the lipids play in the causation of serum-sickness in rabbits. The word lipid is used as an inclusive term embracing all those substances removed from serum by commonly employed solvents such as alcohol, ether and similar materials.
Moyer S Fleisher, Lloyd R Jones
openaire +2 more sources
Frontiers in Allergy, 2023 Several monoclonal antibodies have been approved by the Food and Drug Administration (FDA) to treat allergic disorders, including omalizumab, dupilumab, mepolizumab, reslizumab, benralizumab, tralokinumab and tezepelumab, and their indications continue ...
Andrea Sitek +2 more
doaj +1 more source
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways [PDF]
, 2012 It is of considerable translational importance whether depression is a form or a consequence of sickness behavior. Sickness behavior is a behavioral complex induced by infections and immune trauma and mediated by pro-inflammatory cytokines.
A Bosutti +189 more
core +2 more sources
Case Reports in Medicine, 2012 Serum sickness is an immune-complex-mediated systemic illness that can occur after treatment with monoclonal or polyclonal antibodies such as Rituxan (Rituximab) or antithymocyte globulin (Thymoglobulin), respectively.
Amarpreet Sandhu +3 more
doaj +1 more source
Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome
The Turkish Journal of Pediatrics, 2020 Background. Rituximab is effective for treatment of children with refractory nephrotic syndrome (NS). However, the drug may cause serum sickness characterized by fever, rash, and arthralgia 10-14 days after primary antigen exposure or within a few
Meral Torun Bayram +2 more
doaj +1 more source
Safety aspects of infliximab in inflammatory bowel disease patients - A retrospective cohort study in 100 patients of a German University Hospital [PDF]
, 2004 Background: Infliximab, a chimeric anti-tumour necrosis factor monoclonal antibody with potent anti-inflammatory effects, represents an effective treatment option in patients with severe inflammatory bowel disease (IBD).
Ali Y +11 more
core +1 more source